[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-EP2141150,2010,A1Locationinpatent:Page/Pagecolumn84
1163287-01-1
455-75-4
369-26-6
848678-60-4
1307516-30-8
1215921-77-9
119776-15-7 | 1-(4-(Benzyloxy)-2-fluorophenyl)ethanone | AA01FR4J | MFCD22479738
4371-25-9 | 8-oxa-9λ⁶-thiatricyclo[8.4.0.0²,⁷]tetradeca-1(14),2,4,6,10,12-hexaene-9,9-dione | AA01FRCP
189684-50-2 | N-acetyl-L-α-aspartyl-L-α-glutamyl-L-valyl-N-(4-nitrophenyl)-L-α-asparagine | AA01FS5E
1106313-60-3 | N-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzenesulfonamide | AA01FSDP | MFCD22494655
1689539-29-4 | 5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole | AA00AS2M | MFCD28977193
1354950-38-1 | 1-(pyridine-3-sulfonyl)piperidine-4-carbohydrazide | AA019PQR | MFCD20441561
1214808-81-7 | 2-amino-1-(2,6-dimethylmorpholin-4-yl)-2-phenylethan-1-one hydrochloride | AA019VG8 | MFCD12197198
1221725-36-5 | 2,2,2-trifluoroethyl N-[2-(4-methoxyphenoxy)pyridin-3-yl]carbamate | AA019XZB | MFCD15209538
1178490-41-9 | 5-chloro-3-(2-chlorophenyl)-1,2,4-oxadiazole | AA01A966 | MFCD12774193
1249495-43-9 | cyclohexyl(5-fluoropyridin-3-yl)methanol | AA01AH0W | MFCD14684017
